ROS-responsive small-molecule self-assembled nanocarrier-integrated hydrogels for ulcerative colitis treatment
Overall, an ROS-responsive small-molecule self-assembled nanocarrier-integrated hydrogel (HA/MPC@B) achieved effective UC treatment through the synergistic effects of targeted delivery, ROS-responsive release, anti-inflammatory/antioxidant activities, barrier repair, and microbiota modulation.